Literature DB >> 1281723

Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins.

S Brunelleschi1, A Parenti, E Ceni, A Giotti, R Fantozzi.   

Abstract

1. We have evaluated the ability of substance P (SP), neurokinin A (NKA) and the selective NK2 receptor agonist [beta-Ala8]-NKA(4-10) to induce superoxide anion (O2-) production and prostanoid (prostaglandin E2, thromboxane B2) release from alveolar macrophages (AMs) isolated from control or actively sensitized guinea-pigs. 2. The dose-response curves for NKA and SP were shifted to the left (three orders and one order of magnitude, respectively) in AMs isolated from sensitized animals, with no variation in maximal effects. 3. By evaluating the effects of [beta-Ala8]-NKA(4-10), we observed that not only was the concentration-response curve shifted to the left in both the functional parameters examined, but also maximal effects were significantly enhanced in AMs isolated from sensitized guinea-pigs. 4. This varied responsiveness seems to be specific for tachykinins, as it was not reproduced by another AM stimulant, the bacterial peptide N-formylmethionyl-leucyl-phenylalanine (fMLP). 5. Only small amounts of beta-glucuronidase were released following tachykinin or ovalbumin stimulation both in control and sensitized AMs. 6. These results indicate that AMs isolated from sensitized guinea-pigs show an increased responsiveness to NK2 receptor stimulation and further stress the role played by AMs in allergic lung diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281723      PMCID: PMC1907914          DOI: 10.1111/j.1476-5381.1992.tb13392.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Neuropeptides in the respiratory tract. Part I.

Authors:  P J Barnes; J N Baraniuk; M G Belvisi
Journal:  Am Rev Respir Dis       Date:  1991-11

2.  The binding of monomeric IgG to human blood monocytes and alveolar macrophages.

Authors:  M D Rossman; P Chien; A Cassizzi-Cprek; J A Elias; A Holian; A D Schreiber
Journal:  Am Rev Respir Dis       Date:  1986-02

3.  The macrophage receptor for IgG: number and affinity of binding sites.

Authors:  W P Arend; M Mannik
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

Review 4.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

5.  Arachidonic acid acts as an intracellular activator of NADPH-oxidase in Fc gamma receptor-mediated superoxide generation in macrophages.

Authors:  A Sakata; E Ida; M Tominaga; K Onoue
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

6.  Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge.

Authors:  A Saria; J M Lundberg; G Skofitsch; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

7.  Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients.

Authors:  M Joseph; A B Tonnel; G Torpier; A Capron; B Arnoux; J Benveniste
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

8.  Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics.

Authors:  B Arnoux; M Joseph; M H Simoes; A B Tonnel; P Duroux; A Capron; J Benveniste
Journal:  Bull Eur Physiopathol Respir       Date:  1987 Mar-Apr

9.  Characterization of the IgE Fc receptors on monocytes and macrophages.

Authors:  H L Spiegelberg; G Boltz-Nitulescu; J M Plummer; F M Melewicz
Journal:  Fed Proc       Date:  1983-01

Review 10.  The contribution of alveolar macrophages to hyperreactive airway disease.

Authors:  J A Rankin
Journal:  J Allergy Clin Immunol       Date:  1989-04       Impact factor: 10.793

View more
  7 in total

1.  The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation.

Authors:  K H Banner; E Moriggi; B Da Ros; G Schioppacassi; C Semeraro; C P Page
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway.

Authors:  Claudio Bardelli; Gabriele Gunella; Federica Varsaldi; Pietro Balbo; Elisa Del Boca; Ilaria Seren Bernardone; Angela Amoruso; Sandra Brunelleschi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs.

Authors:  E Boichot; N Germain; V Lagente; C Advenier
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

5.  Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs.

Authors:  M Schuiling; A B Zuidhof; H Meurs; J Zaagsma
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  The role of substance P in myocardial dysfunction during ischemia and reperfusion.

Authors:  H Chiao; R W Caldwell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

7.  Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.

Authors:  M Gallicchio; E Benetti; A C Rosa; R Fantozzi
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.